Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Adenosine signaling and the regulation of chronic lung disease Zhou Y; Schneider DJ; Blackburn MRPharmacol Ther 2009[Jul]; 123 (1): 105-16Chronic lung diseases such as asthma, chronic obstructive pulmonary disease and interstitial lung disease are characterized by inflammation and tissue remodeling processes that compromise pulmonary function. Adenosine is produced in the inflamed and damaged lung where it plays numerous roles in the regulation of inflammation and tissue remodeling. Extracellular adenosine serves as an autocrine and paracrine signaling molecule by engaging cell surface adenosine receptors. Preclinical and cellular studies suggest that adenosine plays an anti-inflammatory role in processes associated with acute lung disease, where activation of the A(2A)R and A(2B)R has promising implications for the treatment of these disorders. In contrast, there is growing evidence that adenosine signaling through the A(1)R, A(2B)R and A(3)R may serve pro-inflammatory and tissue remodeling functions in chronic lung diseases. This review discusses the current progress of research efforts and clinical trials aimed at understanding the complexities of these signaling pathway as they pertain to the development of treatment strategies for chronic lung diseases.|*Signal Transduction[MESH]|Acute Disease[MESH]|Adenosine Deaminase/genetics/physiology[MESH]|Adenosine/*metabolism[MESH]|Animals[MESH]|Chronic Disease[MESH]|Disease Models, Animal[MESH]|Humans[MESH]|Lung Diseases, Interstitial/drug therapy/immunology/*metabolism/pathology[MESH]|Lung Diseases, Obstructive/drug therapy/immunology/*metabolism/pathology[MESH]|Purinergic P1 Receptor Agonists[MESH]|Purinergic P1 Receptor Antagonists[MESH]|Receptors, Purinergic P1/metabolism[MESH] |